Spiro heterocycles as potential inhibitors of SIRT1: Pd/C-mediated synthesis of novel N-indolylmethyl spiroindoline-3,2′-quinazolines
Novel N-indolylmethyl substituted spiroindoline-3,2′-quinazolines were designed as potential inhibitiors of SIRT1. These compounds were synthesized in good yields by using Pd/C–Cu mediated coupling-cyclization strategy as a key step involving the reaction of 1-(prop-2-ynyl)-1′H-spiro[indoline-3,2′-q...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2013-03, Vol.23 (5), p.1351-1357 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1357 |
---|---|
container_issue | 5 |
container_start_page | 1351 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 23 |
creator | Rambabu, D. Raja, Guttikonda Yogi Sreenivas, B. Seerapu, G.P.K. Lalith Kumar, K. Deora, Girdhar Singh Haldar, Devyani Rao, M.V.Basaveswara Pal, Manojit |
description | Novel N-indolylmethyl substituted spiroindoline-3,2′-quinazolines were designed as potential inhibitiors of SIRT1. These compounds were synthesized in good yields by using Pd/C–Cu mediated coupling-cyclization strategy as a key step involving the reaction of 1-(prop-2-ynyl)-1′H-spiro[indoline-3,2′-quinazoline]-2,4′(3′H)-dione with 2-iodoanilides. Some of the compounds synthesized have shown encouraging inhibition of Sir 2 protein (a yeast homologue of mammalian SIRT1) in vitro and three of them showed dose dependent inhibition of Sir 2. The docking results suggested that the benzene ring of 1,2,3,4-tetrahydroquinazolin ring system of these molecules occupied the deep hydrophobic pocket of the protein and one of the NH along with the sulfonyl group participated in strong H-bonding interaction with the amino acid residues. |
doi_str_mv | 10.1016/j.bmcl.2012.12.089 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1288312247</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X12016848</els_id><sourcerecordid>1288312247</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-1a74ea657205826fc743f1b030ffb2043d0c2debe491281fb0c2ba0d01aea1aa3</originalsourceid><addsrcrecordid>eNp9kc1uEzEUhS0EomnhBViAlyw66fVP5gexQRE_lSpApJXYWR7PHeLIM05tp9KwYsf78Eg8CU5SWCJZsnz1nXOtcwh5xmDOgJUXm3k7GDfnwPg8H6ibB2TGZCkLIWHxkMygKaGoG_n1hJzGuAFgEqR8TE64kAyqpp6Rn6utDZ6uMWHwZjIOI9WRbn3CMVntqB3XtrXJh0h9T1eXX67ZK_q5u1gWA3ZWJ-xonMa0xmgPxOjv0NGPhR077yY3YFpPjsb9lsPIjliIc_77x6_idmdH_f0wik_Io167iE_v7zNy8-7t9fJDcfXp_eXyzVVhRA2pYLqSqMtFxWFR87I3lRQ9a0FA37ccpOjA8A5blA3jNevb_Gw1dMA0aqa1OCMvj77b4G93GJMabDTonB7R76LKqlowzmWVUX5ETfAxBuzVNthBh0kxUPsC1EbtC1D7ArJQ5QKy6Pm9_67NAf2T_E08Ay-OQK-90t-CjepmlR0WuR3BKiYz8fpIYM7hzmJQ0VgcTY47oEmq8_Z_P_gDBAOjWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1288312247</pqid></control><display><type>article</type><title>Spiro heterocycles as potential inhibitors of SIRT1: Pd/C-mediated synthesis of novel N-indolylmethyl spiroindoline-3,2′-quinazolines</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Rambabu, D. ; Raja, Guttikonda ; Yogi Sreenivas, B. ; Seerapu, G.P.K. ; Lalith Kumar, K. ; Deora, Girdhar Singh ; Haldar, Devyani ; Rao, M.V.Basaveswara ; Pal, Manojit</creator><creatorcontrib>Rambabu, D. ; Raja, Guttikonda ; Yogi Sreenivas, B. ; Seerapu, G.P.K. ; Lalith Kumar, K. ; Deora, Girdhar Singh ; Haldar, Devyani ; Rao, M.V.Basaveswara ; Pal, Manojit</creatorcontrib><description>Novel N-indolylmethyl substituted spiroindoline-3,2′-quinazolines were designed as potential inhibitiors of SIRT1. These compounds were synthesized in good yields by using Pd/C–Cu mediated coupling-cyclization strategy as a key step involving the reaction of 1-(prop-2-ynyl)-1′H-spiro[indoline-3,2′-quinazoline]-2,4′(3′H)-dione with 2-iodoanilides. Some of the compounds synthesized have shown encouraging inhibition of Sir 2 protein (a yeast homologue of mammalian SIRT1) in vitro and three of them showed dose dependent inhibition of Sir 2. The docking results suggested that the benzene ring of 1,2,3,4-tetrahydroquinazolin ring system of these molecules occupied the deep hydrophobic pocket of the protein and one of the NH along with the sulfonyl group participated in strong H-bonding interaction with the amino acid residues.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2012.12.089</identifier><identifier>PMID: 23410798</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>amino acids ; benzene ; Cancer ; Carbon - chemistry ; Catalysis ; Humans ; Hydrogen Bonding ; hydrophobicity ; Indole ; Indoles - chemical synthesis ; Indoles - chemistry ; Indoles - pharmacology ; mammals ; Models, Molecular ; Palladium - chemistry ; Pd/C ; Quinazoline ; Quinazolines - chemical synthesis ; Quinazolines - chemistry ; Quinazolines - pharmacology ; SIRT1 ; Sirtuin 1 - antagonists & inhibitors ; Sirtuin 1 - chemistry ; Sirtuin 1 - metabolism ; Spiro Compounds - chemical synthesis ; Spiro Compounds - chemistry ; Spiro Compounds - pharmacology ; Structure-Activity Relationship ; yeasts</subject><ispartof>Bioorganic & medicinal chemistry letters, 2013-03, Vol.23 (5), p.1351-1357</ispartof><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-1a74ea657205826fc743f1b030ffb2043d0c2debe491281fb0c2ba0d01aea1aa3</citedby><cites>FETCH-LOGICAL-c380t-1a74ea657205826fc743f1b030ffb2043d0c2debe491281fb0c2ba0d01aea1aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X12016848$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23410798$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rambabu, D.</creatorcontrib><creatorcontrib>Raja, Guttikonda</creatorcontrib><creatorcontrib>Yogi Sreenivas, B.</creatorcontrib><creatorcontrib>Seerapu, G.P.K.</creatorcontrib><creatorcontrib>Lalith Kumar, K.</creatorcontrib><creatorcontrib>Deora, Girdhar Singh</creatorcontrib><creatorcontrib>Haldar, Devyani</creatorcontrib><creatorcontrib>Rao, M.V.Basaveswara</creatorcontrib><creatorcontrib>Pal, Manojit</creatorcontrib><title>Spiro heterocycles as potential inhibitors of SIRT1: Pd/C-mediated synthesis of novel N-indolylmethyl spiroindoline-3,2′-quinazolines</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Novel N-indolylmethyl substituted spiroindoline-3,2′-quinazolines were designed as potential inhibitiors of SIRT1. These compounds were synthesized in good yields by using Pd/C–Cu mediated coupling-cyclization strategy as a key step involving the reaction of 1-(prop-2-ynyl)-1′H-spiro[indoline-3,2′-quinazoline]-2,4′(3′H)-dione with 2-iodoanilides. Some of the compounds synthesized have shown encouraging inhibition of Sir 2 protein (a yeast homologue of mammalian SIRT1) in vitro and three of them showed dose dependent inhibition of Sir 2. The docking results suggested that the benzene ring of 1,2,3,4-tetrahydroquinazolin ring system of these molecules occupied the deep hydrophobic pocket of the protein and one of the NH along with the sulfonyl group participated in strong H-bonding interaction with the amino acid residues.</description><subject>amino acids</subject><subject>benzene</subject><subject>Cancer</subject><subject>Carbon - chemistry</subject><subject>Catalysis</subject><subject>Humans</subject><subject>Hydrogen Bonding</subject><subject>hydrophobicity</subject><subject>Indole</subject><subject>Indoles - chemical synthesis</subject><subject>Indoles - chemistry</subject><subject>Indoles - pharmacology</subject><subject>mammals</subject><subject>Models, Molecular</subject><subject>Palladium - chemistry</subject><subject>Pd/C</subject><subject>Quinazoline</subject><subject>Quinazolines - chemical synthesis</subject><subject>Quinazolines - chemistry</subject><subject>Quinazolines - pharmacology</subject><subject>SIRT1</subject><subject>Sirtuin 1 - antagonists & inhibitors</subject><subject>Sirtuin 1 - chemistry</subject><subject>Sirtuin 1 - metabolism</subject><subject>Spiro Compounds - chemical synthesis</subject><subject>Spiro Compounds - chemistry</subject><subject>Spiro Compounds - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>yeasts</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1uEzEUhS0EomnhBViAlyw66fVP5gexQRE_lSpApJXYWR7PHeLIM05tp9KwYsf78Eg8CU5SWCJZsnz1nXOtcwh5xmDOgJUXm3k7GDfnwPg8H6ibB2TGZCkLIWHxkMygKaGoG_n1hJzGuAFgEqR8TE64kAyqpp6Rn6utDZ6uMWHwZjIOI9WRbn3CMVntqB3XtrXJh0h9T1eXX67ZK_q5u1gWA3ZWJ-xonMa0xmgPxOjv0NGPhR077yY3YFpPjsb9lsPIjliIc_77x6_idmdH_f0wik_Io167iE_v7zNy8-7t9fJDcfXp_eXyzVVhRA2pYLqSqMtFxWFR87I3lRQ9a0FA37ccpOjA8A5blA3jNevb_Gw1dMA0aqa1OCMvj77b4G93GJMabDTonB7R76LKqlowzmWVUX5ETfAxBuzVNthBh0kxUPsC1EbtC1D7ArJQ5QKy6Pm9_67NAf2T_E08Ay-OQK-90t-CjepmlR0WuR3BKiYz8fpIYM7hzmJQ0VgcTY47oEmq8_Z_P_gDBAOjWQ</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>Rambabu, D.</creator><creator>Raja, Guttikonda</creator><creator>Yogi Sreenivas, B.</creator><creator>Seerapu, G.P.K.</creator><creator>Lalith Kumar, K.</creator><creator>Deora, Girdhar Singh</creator><creator>Haldar, Devyani</creator><creator>Rao, M.V.Basaveswara</creator><creator>Pal, Manojit</creator><general>Elsevier Ltd</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130301</creationdate><title>Spiro heterocycles as potential inhibitors of SIRT1: Pd/C-mediated synthesis of novel N-indolylmethyl spiroindoline-3,2′-quinazolines</title><author>Rambabu, D. ; Raja, Guttikonda ; Yogi Sreenivas, B. ; Seerapu, G.P.K. ; Lalith Kumar, K. ; Deora, Girdhar Singh ; Haldar, Devyani ; Rao, M.V.Basaveswara ; Pal, Manojit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-1a74ea657205826fc743f1b030ffb2043d0c2debe491281fb0c2ba0d01aea1aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>amino acids</topic><topic>benzene</topic><topic>Cancer</topic><topic>Carbon - chemistry</topic><topic>Catalysis</topic><topic>Humans</topic><topic>Hydrogen Bonding</topic><topic>hydrophobicity</topic><topic>Indole</topic><topic>Indoles - chemical synthesis</topic><topic>Indoles - chemistry</topic><topic>Indoles - pharmacology</topic><topic>mammals</topic><topic>Models, Molecular</topic><topic>Palladium - chemistry</topic><topic>Pd/C</topic><topic>Quinazoline</topic><topic>Quinazolines - chemical synthesis</topic><topic>Quinazolines - chemistry</topic><topic>Quinazolines - pharmacology</topic><topic>SIRT1</topic><topic>Sirtuin 1 - antagonists & inhibitors</topic><topic>Sirtuin 1 - chemistry</topic><topic>Sirtuin 1 - metabolism</topic><topic>Spiro Compounds - chemical synthesis</topic><topic>Spiro Compounds - chemistry</topic><topic>Spiro Compounds - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>yeasts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rambabu, D.</creatorcontrib><creatorcontrib>Raja, Guttikonda</creatorcontrib><creatorcontrib>Yogi Sreenivas, B.</creatorcontrib><creatorcontrib>Seerapu, G.P.K.</creatorcontrib><creatorcontrib>Lalith Kumar, K.</creatorcontrib><creatorcontrib>Deora, Girdhar Singh</creatorcontrib><creatorcontrib>Haldar, Devyani</creatorcontrib><creatorcontrib>Rao, M.V.Basaveswara</creatorcontrib><creatorcontrib>Pal, Manojit</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rambabu, D.</au><au>Raja, Guttikonda</au><au>Yogi Sreenivas, B.</au><au>Seerapu, G.P.K.</au><au>Lalith Kumar, K.</au><au>Deora, Girdhar Singh</au><au>Haldar, Devyani</au><au>Rao, M.V.Basaveswara</au><au>Pal, Manojit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spiro heterocycles as potential inhibitors of SIRT1: Pd/C-mediated synthesis of novel N-indolylmethyl spiroindoline-3,2′-quinazolines</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2013-03-01</date><risdate>2013</risdate><volume>23</volume><issue>5</issue><spage>1351</spage><epage>1357</epage><pages>1351-1357</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Novel N-indolylmethyl substituted spiroindoline-3,2′-quinazolines were designed as potential inhibitiors of SIRT1. These compounds were synthesized in good yields by using Pd/C–Cu mediated coupling-cyclization strategy as a key step involving the reaction of 1-(prop-2-ynyl)-1′H-spiro[indoline-3,2′-quinazoline]-2,4′(3′H)-dione with 2-iodoanilides. Some of the compounds synthesized have shown encouraging inhibition of Sir 2 protein (a yeast homologue of mammalian SIRT1) in vitro and three of them showed dose dependent inhibition of Sir 2. The docking results suggested that the benzene ring of 1,2,3,4-tetrahydroquinazolin ring system of these molecules occupied the deep hydrophobic pocket of the protein and one of the NH along with the sulfonyl group participated in strong H-bonding interaction with the amino acid residues.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>23410798</pmid><doi>10.1016/j.bmcl.2012.12.089</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2013-03, Vol.23 (5), p.1351-1357 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_1288312247 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | amino acids benzene Cancer Carbon - chemistry Catalysis Humans Hydrogen Bonding hydrophobicity Indole Indoles - chemical synthesis Indoles - chemistry Indoles - pharmacology mammals Models, Molecular Palladium - chemistry Pd/C Quinazoline Quinazolines - chemical synthesis Quinazolines - chemistry Quinazolines - pharmacology SIRT1 Sirtuin 1 - antagonists & inhibitors Sirtuin 1 - chemistry Sirtuin 1 - metabolism Spiro Compounds - chemical synthesis Spiro Compounds - chemistry Spiro Compounds - pharmacology Structure-Activity Relationship yeasts |
title | Spiro heterocycles as potential inhibitors of SIRT1: Pd/C-mediated synthesis of novel N-indolylmethyl spiroindoline-3,2′-quinazolines |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T10%3A49%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spiro%20heterocycles%20as%20potential%20inhibitors%20of%20SIRT1:%20Pd/C-mediated%20synthesis%20of%20novel%20N-indolylmethyl%20spiroindoline-3,2%E2%80%B2-quinazolines&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Rambabu,%20D.&rft.date=2013-03-01&rft.volume=23&rft.issue=5&rft.spage=1351&rft.epage=1357&rft.pages=1351-1357&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2012.12.089&rft_dat=%3Cproquest_cross%3E1288312247%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1288312247&rft_id=info:pmid/23410798&rft_els_id=S0960894X12016848&rfr_iscdi=true |